Identification of Monobenzone as a Novel Potential Anti-Acute Myeloid Leukaemia Agent That Inhibits RNR and Suppresses Tumour Growth in Mouse Xenograft …

J Dong, T Zhong, Z Xu, H Chen, X Wang, L Yang, Z Lou… - Cancers, 2022 - mdpi.com
Simple Summary The clinical treatment of acute myeloid leukaemia is still dominated by
chemotherapy. Clinically used anti-leukaemia drugs have shortcomings such as …

[PDF][PDF] Prognostic Assessment of P-Glycoprotein over Expression in Refractory and/or Relapsed Acute Myeloid Leukemia and Response to Cyclosporine A

AM El Hefni, FMA Taleb, KM Hadhoud… - Life Science …, 2013 - lifesciencesite.com
Acute myeloid leukemia (AML) is a malignant hematopoietic neoplasm characterized by
clonal proliferation of tumor cells that arise from the hematopoietic stem/progenitor …

[引用][C] VEGF 和MDR1 在急性髓系白血病中的表达及其与预后关系研究

李晓明, 韩建群 - 现代肿瘤医学, 2006

[引用][C] MDR1 在急性髓系白血病中的表达及其与预后的关系

范红, 程远东, 范梅, 姚反修, 孙哲, 吕晓东 - 山东医药, 2009

[引用][C] MDR-1 在急性髓系白血病中表达的研究

吴胜军, 陈光, 黄珺, 金春兰, 金红, 张钧, 谢鑫友 - 浙江医学, 2012

[引用][C] P-GLYCOPROTEIN EXPRESSION LEVEL AND ITS SIGNIFICANCE IN INDUCTION OF REMISSION IN CHILDHOOD ACUTE LEUKEMIA

THM Hassan - 2005 - Zagazig University